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Abstract Fatty acid binding protein 3 (FABP3) is a
member of a family of binding proteins. The protein is
mainly expressed in cardiac and skeletal muscle cells, and
it has been linked to fatty acid metabolism, trafﬁcking, and
signaling. Using suppression subtractive hybridization, we
previously found that FABP3 is highly regulated in
ventricular septal defect (VSD) patients and may play a
signiﬁcant role in the development of human VSD.
We therefore aimed to identify the biological characteris-
tics of the FABP3 gene in embryonic myocardial cells. On
the basis of RT-PCR and western blotting analyses, we
demonstrated that the expression levels of FABP3 mRNA
and protein were up-regulated initially and then gradually
decreased with P19 cell differentiation. MTT assays and
cell cycle analysis showed that FABP3 inhibits P19 cell
proliferation, and data from annexin V-FITC assays
revealed that FABP3 can promote apoptosis of P19 cells.
Further data from quantitative real-time RT-PCR revealed
lower expression levels of cardiac muscle-speciﬁc molec-
ular markers (cTnT, alpha-MHC, GATA4, and MEF2c) in
FABP3-overexpressing cell lines than in the control cells
during differentiation. Our results demonstrate that FABP3
may be involved in the differentiation of cardiac myocytes.
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Introduction
Congenital heart disease (CHD) is the most common type
of birth defect, the incidence of which has been reported to
vary approximately from 4/1,000 to 50/1,000 live births
[1, 2]. Ventricular septal defect (VSD) is the most common
form of CHD and among the most frequently encountered
of congenital abnormalities [3]. As a multifactorial com-
plex disease, environmental, and genetic factors have been
identiﬁed that could play important roles in the formation
of an interventricular septum. Currently, rapid progress in
molecular markers and developmental biology is being
made with regard to CHD. However, to date, very few
VSD-causing genes have been identiﬁed. Thus, the iden-
tiﬁcation and characterization of novel genes and proteins
associated with VSD remains an important issue.
Fatty acid-binding protein 3 (FABP3) is a low molecular
weight protein with distinct tissue distribution, which may
play an important role in fatty acid transport, cell growth,
cellular signaling, and gene transcription [4, 5]. FABP3 is
upregulated during terminal differentiation of mouse
cardiomyocytes [6]. In previous studies using suppression
subtractive hybridization, we identiﬁed genes that were
differentially expressed in VSD and normal ventricular
septum myocardium [7]. We found that FABP3 is more
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myocardium. Therefore, we selected this protein for further
analysis. The P19 mouse teratocarcinoma cell line is one of
the suitable models for cardiac differentiation at the
molecular and functional levels [8]. Therefore, we selected
the P19 cell line to investigate the effects of FABP3 on
cardiac differentiation, proliferation, and apoptosis, and
determined the expression level of cardiac troponin I
(cTnT) gene protein to conﬁrm the differentiation of car-
diac precursors into mature cardiomyocytes [9]. In this
study, we initially examined the changes in FABP3 mRNA
and protein expression during the differentiation of P19
cells to cardiac myocytes. We then went on to examine the
effect of FABP3 on cell differentiation, proliferation, and
apoptosis by establishing a stable P19 cell line over-
expressing FABP3, and found that the expression levels of
FABP3 mRNA and protein were up-regulated initially and
then gradually decreased with P19 cell differentiation.
Overexpression of FABP3 in P19 cells inhibits prolifera-
tion and promotes apoptosis of these cells. P19 cell lines
overexpressing FABP3 also showed lower expression lev-
els of cardiac muscle-speciﬁc molecular markers when
compared with the control cells. These results suggest that
the FABP3 gene may be involved in the differentiation of
cardiac myocytes.
Materials and Methods
Cell Culture
The P19 cells used in this study were obtained from the
American Type Culture Collection (ATCC, Manassas, VA,
USA). The cells were cultured in a-modiﬁed Eagle’s
medium (a-MEM; Gibco BRL, Grand Island, NY, USA)
supplemented with 10% fetal bovine serum (FBS; Gibco
BRL), 100 U/ml penicillin, and 100 lg/ml streptomycin at
37Ci n5 %C O 2. In order to induce cardiac differentiation,
embryoid body (EB) formation was induced by plating
1 9 10
6 P19 cells in 10-cm bacterial dishes containing
15 ml of a-MEM supplementedwith 1% DMSO (Sigma,St.
Louis, MO, USA), 10% FBS, 100 U/ml penicillin, and
100 lg/ml streptomycin for 96 h. The resulting EBs were
transferred to 6-cm bacterial dishes, and cultured in a-MEM
containing 10% FBS for an additional 4 or 6 days. Mor-
phological changes in the P19 cells were examined and
photographed under an inverted microscope (Nikon, Japan).
Establishment of a Stable Cell Line Overexpressing
Fabp3
The coding sequence of FABP3 was subcloned into the
EcoRI/XhoI sites of a pcDNA3.1/myc-His B expression
vector, using the oligonucleotides 50-AGCTGAATTCTGC
AATGGCGGACGCCTTTGTC-30 and 50-AGCTCTCG
AGCGCGCCT CCT TCT CATAAG-30 to generate a
plasmid expressing a FABP3-6 9 His fusion protein.
Expression vectors carrying the FABP3 coding sequence
or empty vectors were transfected into P19 cells. Two
days after transfecton, neomycin (G418; Roche, Basel,
Switzerland) was added to the medium (600 lg/ml) to
select transfected cells. After 2 weeks, individual colonies
were isolated, propagated, and the expression of the
FABP3-6 9 His fusion protein was conﬁrmed by western
blotting using an anti-6 9 His antibody (Clontech, Moun-
tain View, CA). The colonies expressing the highest levels
of FABP3 were selected for study.
MTT Assay
To analyze the growth of stably transfected P19 cells, the
cells (2.5 9 10
2/well) were seeded in 96-well plates and
cultured in a-MEM supplemented with 10% FBS. Cell
growth was monitored for 5 days using a Cell Proliferation
MTT Kit (Roche Diagnostics, GmBH, Mannheim, Ger-
many) as recommended by the manufacturer. The absor-
bance at 550 and 690 nm was recorded using an ELISA
reader, and the OD was calculated as the difference
between absorbances at the two wavelengths.
Cell Cycle Assay
Cells were incubated at a density of 2 9 10
6 cells/
750 mm
2 in a-MEM containing 10% FBS, then washed
with PBS and starved in serum-free a-MEM for 24 h to
synchronize. The cell cycle was initiated by replacement of
the starvation medium with full medium (a-MEM con-
taining 10% FBS) for various times (0, 12, 18, and 24 h)
after serum deprivation. Cultured cells were harvested
using trypsin/EDTA and washed twice with PBS. Aliquots
of 2 9 10
6 cells were centrifuged, ﬁxed in 70% ethanol,
and stained with 500 ll of propidium iodide (PI) solution
(100 lg/ml RNase and 50 lg/ml PI in 1 9 PBS). Labeled
cells were analyzed using a BD FACScan and the data
were analyzed using CellQuest software.
Apoptosis Assay
Cells were cultured in FBS-free a-MEM for 24 h to induce
apoptosis. Cells were then harvested using trypsin/EDTA
at 0 and 24 h after replacing the FBS-free a-MEM with full
medium (a-MEM containing 10% FBS), washed with PBS,
resuspended in 1 ml binding buffer, and stained with 10 ll
lnnexin V-FITC and 10 ll PI at room temperature for
5 min (Biovision, CA, USA). The ﬂuorescence of FITC
and PI was analyzed by ﬂow cytometry.
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123Western Blotting
Cultured cells were directly transferred to tubes containing
lysis buffer (50 mmol/l Tris–HCl, 1% Triton X-100, 0.2%
sodium deoxycholate, 0.2% SDS, and 1 mmol/l EDTA at
pH 7.4) and vortexed brieﬂy. The lysate supernatant was
collected after centrifugation at 15,200g for 15 min at 4C.
Protein concentration determinations using a protein assay
reagent kit, and western blotting using a monoclonal rabbit
anti-cTnT antibody (CHEMICON, USA), anti-FABP3
antibody (Genetex, USA), and a monoclonal rabbit anti-
GAPDH antibody (Proteintech Group, Inc., China), were
performed as described previously [10].
RT-PCR
Total RNA was isolated from cultured P19 cells using the
TRIzolmethod(Invitrogen,Carlsbad,CA,USA).cDNAwas
synthesized from 1 lg of total RNA using an AMV Reverse
Transcriptase Kit (PromegaA3500;Promega, Madison, WI,
USA). An aliquot (10%) of the resulting cDNA was ampli-
ﬁed with the primerslisted in Table 1.The numberof cycles
and reaction temperatures used in the PCR assay were
optimized to provide a linear relationship between the
amount of input template and the amount of PCR product.
Establishment of a Stable Cell Line Overexpressing
Fabp3
For overexpression studies, FABP3-pcDNA3.1/myc-His
B(?) was constructed by inserting the PCR ampliﬁed ORF
of FABP3 into EcoRI and XhoI sites of the vector. The
primers used to clone the open-reading frame of FABP3
cDNA were 50-AGCTGAATTCTGCAATGGCGGACGC
CTTTGTC-30 and 50-AGCTCTCGAGCGCGCCT CCT
TCT CATAAG-30. Expression vectors carrying the FABP3
coding sequence, or empty vectors, were transfected into
P19 cells. At 48 h after transfection, neomycin (G418,
Roche) was added to the medium (600 lg/ml) to select
transfected cells. After 2 weeks, individual colonies were
isolated, propagated, and the expression of the FABP3-
6 9 His fusion protein was conﬁrmed by western blot. The
anti-6 9 His antibody used was from Clontech. Colonies
expressing the highest levels of FABP3 were selected for
cell studies.
Quantitative Real-Time RT-PCR
Total RNA was extracted from P19 cells using TRIzol
reagent (Invitrogen). cDNA was then synthesized from
1 lg of total RNA using the AMV Reverse Transcriptase
Kit (Promega). Real-time PCR was performed using the
SYBR Green method in an Applied Biosystems 7300
Sequence Detection System (ABI 7300 SDS; Foster City,
CA, USA) following the manufacturer’s protocols. The
PCR conditions included a denaturation step (95C for
10 min), and ampliﬁcation and quantiﬁcation were repe-
ated 40 times (95C for 15 s, 60C for 1 min). The mea-
surement of gene expression was performed in triplicate.
The relative gene expression levels were quantiﬁed based
on the Ct, and normalized to the reference gene GAPDH.
The sequences of the primers used are shown in Table 2.
Each sample was measured in duplicate, and the gene
expression levels were calculated by the 2
-DDCT method as
described previously [11].
Statistical Analysis
Each experiment was performed at least three times. All
values are presented as the mean ± SD. Statistical
analysis was performed using one-way ANOVA and
t-o rt0 tests with a correction for multiple comparisons,
as appropriate. Statistical signiﬁcance was assumed when
P\0.05.
Table 1 Primer sequences and
annealing temperature used in
PCR
Gene Sequences (50–30) Product size (bp) Annealing
temperature (C)
Cycles
FABP3 F: ACCAAGCCTACTACCATCATC 285 54.7 24
R: GTCACGACCTCCTTCTCAT
GAPDH F: ACCACAGTCCATGCCATCAC 450 60.7 20
R: TCCACCACCCTGTTGCTGTA
Table 2 Primer sequences and product size used in quantitative real-
time RT–PCR
Gene Sequences (50–30) Product
size (bp)
cTnT F: CAGAGGAGGCCAACGTAGAAG 138
R: CTCCATCGGGGATCTTGGGT
a-MHC F: GCCCAGTACCTCCGAAAGTC 110
R: GCCTTAACATACTCCTCCTTGTC
GATA4 F: CCCTACCCAGCCTACATGG 139
R: ACATATCGAGATTGGGGTGTCT
MEF2c F: TGTCCAGCCATAACAGTTTGG 177
R: CCTTGTGAACATGAAGTCCTCTT
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Appraisal of Cell Differentiation
To investigate the differentiation of P19 cells into mature
cardiomyocytes, we used western blotting to identify the
expression of cTnT protein after the beating of cells
was observed. In Fig. 1, we show the increase in cTnT
expression.
The Changes in Fabp3 Mrna and Protein Expression
During Differentiation
When P19 cells were induced to differentiate to cardiac
myocytes, the expression level of FABP3 mRNA had a
tendency to down-regulate gradually from d0 to d6, and
there were signiﬁcant differences between d0 and d2–4 and
between d2–4 and d5–6 (Fig. 2a). However, there was no
signiﬁcant difference in the expression level of FABP3
protein between d0 and d2–4, even though the expression
pattern of FABP3 protein during the differentiation of P19
cells was the same as that of FABP3 mRNA, with the
lowest expression at d4 of differentiation. FABP3 mRNA
expression had a tendency to up-regulate after d5 gradu-
ally. The western blot results were consistent with those of
RT-PCR (Fig. 2b).
Establishment of Stable Overexpressing FABP3 P19
Cells
Stable FABP3-overexpressing P19 cells and the empty-
vector controls were established and maintained in a-MEM
containing 250 lg/ml G418. FABP3 protein expression
was veriﬁed by western blot analysis (Fig. 3).
Effect of FABP3 on Cell Differentiation
In Fig. 4a, we show that there was no signiﬁcant difference
in the morphology of P19 cell lines overexpressing the
FABP3 gene on days 0, 4, and 12 of differentiation and the
control cells. However, when we used quantitative real-
time RT PCR to analyze the expression of cardiac muscle-
speciﬁc molecular markers (cTnT, alpha-MHC, GATA4,
MEF2c) in these cells during differentiation, we found that
cell lines overexpressing FABP3 showed lower expression
Fig. 2 The changes in FABP3 mRNA expression during differenti-
ation. a The changes in FABP3 mRNA expression during differen-
tiation were conﬁrmed by RT-PCR. b Western blotting shows the
changes in FABP3 protein expression during differentiation. The
results represent the mean ± SD of six experiments
Fig. 1 Appraisal of cell differentiation. Western blot analysis of
cTnT protein during differentiation
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123levels of these marker genes when compared with the
control cells at days 6, 8, and 12 (Fig. 4b).
Effect of FABP3 on Cell Proliferation
Cell growth was analyzed by MTT assay every day for
a period of 5 days. P19 cells stably transfected with
pcDNA3.1Myc/HisB vector served as controls. As shown
in Fig. 5a, control cells had a considerably higher prolif-
eration rate compared with cells with ectopic expression of
FABP3 (* P\0.05, ** P\0.001). Cell cycle analysis
was used to further evaluate the effect of FABP3 on cell
proliferation., Data from ﬂow cytometry assays shows that,
more than 60% cells of both cell lines stayed in G1 phase
after starvation of serum for 48 h. Compared with the
control cells, overexpression of FABP3 prevents P19 cells
entering into the S-phase from 18 h after serum stimulation
(* P\0.05) (Fig. 5b).
Effect of FABP3 on Cell Apoptosis
Annexin V-FITC binds to phosphatidylserine and can be
used to detect the early stages of apoptosis [12]. To study
the effect of FABP3 on cell apoptosis, cells were cultured
in FBS-free a-MEM for 24 h to induce apoptosis. Apop-
totic cells were quantiﬁed by ﬂow cytometric analysis after
staining with Annexin V-FITC. This showed that FABP3
promotes P19 cell apoptosis when the cells were induced
by serum deprivation (* P\0.05) (Fig. 6).
Discussion
Observational epidemiological studies of CHD have dem-
onstrated the existence of gene predispositions [13]; how-
ever, the genetic basis of the majority of CHD remains
unknown. To date, only a few genes or markers as critical
regulators of heart formation have been identiﬁed as being
associated with CHD; these include NKX2.5 [14], Tbx5
[15], and GATA4 [16]. Nevertheless, for most CHDs, the
basic pathogenetic mechanism of VSD is still unclear.
Previous studies have shown that FABP3 is expressed in
mouse neonatal hearts and its expression is up-regulated in
these hearts during cardiomyocyte terminal differentiation
[6]. Recently, Seino et al. [17] suggested that FABP3 may
be used as a biomarker for acute coronary syndrome.
However, our subtractive hybridization experiments were
performed on post-natal hearts, we found that FABP3 is
highly regulated in VSD patients compared with normal
controls [7]. This result suggests that FABP3 plays a role in
human VSD.
In this study, using RT-PCR and western blotting, we
found that the expression levels of FABP3 mRNA and
protein were up-regulated initially and then gradually
decreased with P19 cell differentiation. However, statisti-
cal analysis of the data showed that although FABP3
mRNA expression was signiﬁcantly different in P19 cell
suspensions during the induction phase (d0–d4), there was
no signiﬁcant difference in protein expression. The reason
for the difference in FABP3 mRNA and protein expres-
sions is not clear. A similar phenomenon was observed
when Wang et al. [18] used in situ hybridization to detect
B-FABP mRNA expression levels and immunohisto-
chemical techniques to analyze protein expression levels in
undifferentiated breast cancer cells. They considered the
possibility that the FABP mRNA is not translated into
protein. Since FABP3 and B-FABP genes belong to the
same family and are highly homologous [19], we believe
that differences in the expression patterns of FABP3
mRNA and protein at d0–d4 may be because some tran-
scripts in the P19 cells remain untranslated at the d0 stage.
Further work is required to assess this possibility. FABP3
mRNA and protein expression levels decreased gradually
when P19 cells were inducted in suspension (after d0) to
the stages of adherent culture induction (after d4–5), and
then the gene expression gradually increased with the dif-
ferentiation of P19 cells into mature cardiomyocytes.
Therefore, we consider that the FABP3 gene may inhibit
P19 cell differentiation into cardiac cells in the early stages
of cell differentiation. On the basis of our previous studies
showing that FABP3 is abundantly expressed in VSD
myocardium, we demonstrated that the FABP3 gene may
inhibit the differentiation of cardiac cells.
CHD is closely related to the differentiation, prolifera-
tion, and apoptosis of myocardial cells [20, 21]. Therefore,
we investigated the effects of FABP3 on P19 cell differ-
entiation, proliferation, and apoptosis by establishing a
stably transfected P19 cell line overexpressing FABP3.
First, the MTT assay showed that P19 cells overexpressing
FABP3 grew slower than control cells, and cell cycle
analysis by ﬂow cytometry showed a remarkable decrease
Fig. 3 Establishment of stable overexpressing FABP3 P19 cells.
Western blot analysis of FABP3 expression. P19 cells were transfec-
ted with pcDNA3.1Myc/HisB-FABP3 or empty vector. Total cellular
protein was extracted from the cells and subjected to western blot
analysis. The experiment was repeated three times with similar results
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123Fig. 4 Effect of FABP3 on cell
differentiation. a There was no
signiﬁcant difference in the
morphology of P19 cell lines
overexpressing the FABP3 gene
on days 0, 4, and 12 of
differentiation and the control
cells. b Expression of cardiac
muscle-speciﬁc molecular
markers (cTnT, alpha-MHC,
GATA4, and MEF2c) was
analyzed by quantitative real-
time RT-PCR at various time
points during the stimulation of
differentiation (days 6, 8, and
12). The results represent the
mean ± SD of six experiments
(*P\0.05, **P\0.001)
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123in the percentage of cells entering the S-phase. Second,
annexin V-FITC analysis indicated that FABP3 can pro-
mote apoptosis induced by serum deprivation. These data
showed that FABP3 inhibits proliferation and promotes
apoptosis of embryonic myocardial cells. Furthermore, we
also investigated the expression of cardiac muscle-speciﬁc
molecular markers (cTnT, alpha-MHC, GATA4, and MEF2c)
by quantitative real-time RT-PCR in cell lines over-
expressing FABP3 during differentiation. The results
showed that the expression levels of these marker genes
were signiﬁcantly lower in the cell lines overexpressing
FABP3 than in control cells at days 6, 8, and 12. We
therefore consider that FABP3 may be able to signiﬁcantly
affect the differentiation of cardiac precursors into mature
cardiomyocytes, and show inhibitory effects.
In summary, we have characterized several features of
the FABP3 gene, which may play an important role in the
differentiation of cardiac myocytes. Further studies using
either knockdown or knockout cells with attenuated
FABP3 expression, which may provide insights into the
pathogenesis of CHD, are required.
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